DRG (Diagnosis Related Groups) timing crucial for German healthcare system, say doctors
This article was originally published in Clinica
If the government forces an early introduction of the DRG (Diagnosis Related Groups) system in Germany, expect many clinics to disappear," warns Dr Frank Ulrich Montgomery, principal chairman of the Marburger Bund, the association of hospital-based doctors and medical staff. Commenting on the recently issued second draft of the DRG law, he said that the government was deluding itself to think that an early introduction would be successful, given the widely held view that there remain many problems to overcome. Moreover, the latest changes to the DRG draft law showed officials in the ministry of health to be panicking and desperately trying to conceal cracks in the system at the eleventh hour, said Dr Montgomery.
You may also be interested in...
Liquid biopsy start-up Grail Inc. announced that a study of almost 6,700 participants found that its blood test could detect more than 50 types of cancer with a low false-positive rate. See what Minetta Liu, study co-lead author and a Mayo Clinic professor of oncology, had to say about the research.
Sanofi’s next-generation meningococcal vaccine, broader use of Bristol-Myers Squibb’s Reblozyl move toward approval; United Therapeutics foreshadows Trevyent regulatory difficulties.
Biopharma is working on a reputation renaissance as the public looks to industry for treatments and vaccines for the COVID-19 epidemic and drug pricing concerns take a back seat.